NCT02058602 Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase PHASE1
NCT02055456 Nandrolone Decanoate in the Treatment of Telomeropathies Status COMPLETED Phase PHASE1/PHASE2
NCT02052297 A Validation and Dosimetry Study of GSK2634673F PET Ligand Status TERMINATED Phase PHASE1
NCT02048644 Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Status COMPLETED Phase PHASE2
NCT02019641 The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease Status COMPLETED Phase NA
NCT02009293 The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT01979952 Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3
NCT01919827 Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT01890265 Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01874223 Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF Status COMPLETED Phase N/A
NCT01872689 A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01809574 The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease Status UNKNOWN Phase N/A
NCT01777737 Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole Status TERMINATED Phase PHASE3
NCT01772667 Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis Status COMPLETED Phase NA